This symposium will bring together chemists from industry, academia and start-up companies from around the world and is focused on the most recent advances in new synthetic methodologies, total synthesis, fluorination approaches, bioisosteres and building blocks, chemical biology, medicinal chemistry, drug discovery and development leading to new or improved methods for the synthesis of pharmaceuticals.
Beyond key lectures in synthetic and fluorination chemistry, as well as recent case studies in medicinal chemistry and drug discovery, the symposium aims at bridging the range from ‘small molecules’ to ‘large molecules’ including carbohydrates, natural products, novel protein scaffolds and genes; it is expected to attract experts in synthetic chemistry, medicinal chemistry, total synthesis, catalysis, drug discovery, molecular imaging, and chemical development.
The general concept of the meeting, with talks equally selected from industry and academia, will include an opening lecture, 26 invited lectures, 10 short communications selected from submitted abstracts and a large poster session and commercial exhibition. The organisers are very happy to announce that the symposium will be chaired by:
Karin BRINER (Novartis, United States)
Erick M. CARREIRA (ETH Zurich, Switzerland)
In connection with EFMC-ASMC'17, the EFMC organises the 4th EFMC Young Medicinal Chemist Symposium(EFMC-YMCS) which will take place at the University of Vienna on August 31 and September 1, 2017. Participants registered to EFMC-ASMC'17 can benefit from a special rate for their participation in EFMC-YMCS 2017 and students can register for free! Find out more on the EFMC-YMCS website.
